Skip to content
2000
Volume 7, Issue 8
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Accumulating evidence indicates that cancer is maintained by cancer stem cells (CSC). The goal of molecular imaging is to detect pathologic biomarkers, which can lead to early recognition of cancer, better therapeutic management, and improved monitoring for recurrence. The main focus of this review is to describe the different classes of tracers, contrast agents and dyers, and their putative application to improve cancer stem cells detection and follow-up. Although the in vivo cancer diagnosis has not significantly changed for the past three decades, however, in the future it might be possible to trace all cancer cells, including the cancer stem cells.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955707781387894
2007-08-01
2025-06-29
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955707781387894
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test